Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and lifestyle modifications ...

People with severe hemophilia A are at risk for prolonged bleeding events that can cause serious complications. To prevent these bleeding events, most people with this condition get injections of ...

Alhemo (concizumab-mtci) is approved to prevent or reduce bleeding problems in people with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.

For centuries, hemophilia was a dangerous genetic disorder with no treatment. Children with hemophilia often didn't make it to adulthood, since a bump or fall could cause massive internal bleeding ...

Total knee replacement is frequently needed by hemophilia patients and greatly improves their quality of life, but it carries a higher risk of bleeding and infection for hemophiliacs than it does ...

Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX va ...

Learn about potential complications of hemophilia, including what contributes to them, how doctors treat them, and how you can prevent them.

Pfizer PFE announced that the phase III BASIS study evaluating its anti-TFPI inhibitor Hympavzi (marstacimab) for treating patients with hemophilia A or B with inhibitors met its primary endpoint ...

No matter how you contracted Porphyric Hemophilia in Oblivion Remastered, there’s only one surefire way to cure the affliction: magic.

Gene therapy for hemophilia is highly expensive, although proponents noted that insurers may save money over the long run if patients don’t require prophylactic treatment or therapy for bleeds.

Topline data were announced from a phase 3 trial evaluating marstacimab for adults and adolescents living with hemophilia A or B with inhibitors.

For children with severe hemophilia A, once-weekly prophylaxis with efanesoctocog alfa is associated with high sustained factor VIII activity, resulting in effective prevention of bleeding ...